349 related articles for article (PubMed ID: 14695131)
1. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
Pantel K; Müller V; Auer M; Nusser N; Harbeck N; Braun S
Clin Cancer Res; 2003 Dec; 9(17):6326-34. PubMed ID: 14695131
[TBL] [Abstract][Full Text] [Related]
2. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
3. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
4. BM micrometastases and circulating tumor cells in breast cancer patients: where have we been, where are we now and where does the future lie?
Müller V; Pantel K
Cytotherapy; 2005; 7(6):478-82. PubMed ID: 16306009
[TBL] [Abstract][Full Text] [Related]
5. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
6. [Minimal residual disease in breast cancer: detection and clinical relevance].
Pantel K; Wölfle U
Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
[TBL] [Abstract][Full Text] [Related]
7. Micrometastasis in breast cancer and other solid tumors.
Pantel K; Woelfle U
J Biol Regul Homeost Agents; 2004; 18(2):120-5. PubMed ID: 15471214
[TBL] [Abstract][Full Text] [Related]
8. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
9. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
[TBL] [Abstract][Full Text] [Related]
10. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
Fehm T; Braun S; Muller V; Janni W; Gebauer G; Marth C; Schindlbeck C; Wallwiener D; Borgen E; Naume B; Pantel K; Solomayer E
Cancer; 2006 Sep; 107(5):885-92. PubMed ID: 16874814
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of disseminated tumor cells in breast cancer.
Slade MJ; Coombes RC
Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
[TBL] [Abstract][Full Text] [Related]
13. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
Wiedswang G; Borgen E; Kåresen R; Qvist H; Janbu J; Kvalheim G; Nesland JM; Naume B
Clin Cancer Res; 2004 Aug; 10(16):5342-8. PubMed ID: 15328170
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour cells in cancer patients: challenges and perspectives.
Pantel K; Alix-Panabières C
Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in the bone marrow of patients with breast cancer.
Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
[TBL] [Abstract][Full Text] [Related]
16. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells and bone marrow micrometastasis.
Alix-Panabières C; Riethdorf S; Pantel K
Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
[TBL] [Abstract][Full Text] [Related]
18. Micrometastatic disease in breast cancer: clinical implications.
Ignatiadis M; Georgoulias V; Mavroudis D
Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
[TBL] [Abstract][Full Text] [Related]
20. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]